LTRN Lantern Pharma Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$2.58
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026

LTRN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$2.58
Market Cap
P/E (TTM)
-1.9
EPS (TTM)
$-1.57
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$1 – $5

LTRN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS $-1.57
4-point trend, -19.8%
2022-12-31 2025-12-31
Free Cash Flow
2-point trend, -12.3%
2022-12-31 2023-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
LTRN
Peer Median
P/E (TTM)
4-point trend, +58.1%
-1.9

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
LTRN
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
LTRN
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
LTRN
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
LTRN
Peer Median
EPS (Diluted)
4-point trend, -19.8%
$-1.57

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
LTRN
Peer Median

LTRN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

2 analysts · 2026-08-17
Median target $17.50 +578.3%
Mean target $17.50 +578.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.08%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.28 $-0.39 0.11%
March 31, 2026 $-0.30 $-0.37 0.07%
Dec. 31, 2025 $-0.36 $-0.47 0.11%
Sept. 30, 2025 $-0.39 $-0.48 0.09%
June 30, 2025 $-0.40 $-0.49 0.09%
March 31, 2025 $-0.42 $-0.50 0.08%
Dec. 31, 2024 $-0.54 $-0.52 -0.02%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
LTRN -1.9
BTAI $36M -0.3 -71.7% -10887.4% 68.8%
QNCX $187M -2.0 700.5%
BYSI 3.1%
GRML -104.9%
ESLA -4.5
LITS $16M -1.0 33.8% -81.7%
GRDX $20M -1.1 -17634.4% -68.6% -1813.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 11
Annual Income Statement data for LTRN
Metric Trend 2025202420232022202120202019
R&D Expense 6-point trend, +413.3% $12M $16M $12M $9M $8M $2M ·
SG&A Expense 7-point trend, +338.3% $6M $6M $6M $6M $5M $4M $1M
Operating Expenses 7-point trend, +640.4% $18M $22M $18M $14M $13M $6M $2M
Operating Income 5-point trend, -42.8% $-18M $-22M $-18M $-14M $-13M · ·
Other Non-op 5-point trend, +162.3% $421.1K $692.9K $1M $-31.5K $160.6K · ·
Net Income 7-point trend, -605.0% $-17M $-21M $-16M $-14M $-12M $-6M $-2M
EPS (Basic) 5-point trend, -38.9% $-1.57 $-1.93 $-1.47 $-1.31 $-1.13 · ·
EPS (Diluted) 4-point trend, -19.8% $-1.57 $-1.93 $-1.47 $-1.31 · · ·
Shares (Basic) 5-point trend, -0.1% 10,898,175 10,762,319 10,842,365 10,850,579 10,904,927 · ·
Shares (Diluted) 4-point trend, +0.4% 10,898,175 10,762,319 10,842,365 10,850,579 · · ·
EBITDA 4-point trend, -527341.9% · · $-18M $-14M $6.8K $3.4K ·
Balance Sheet 18
Annual Balance Sheet data for LTRN
Metric Trend 2025202420232022202120202019
Cash & Equivalents 7-point trend, +259.0% $4M $8M $22M $37M $52M $19M $1M
Short-term Investments 5-point trend, -70.3% $6M $17M $19M $18M $19M · ·
Prepaid Expense 7-point trend, +86695.4% $683.9K $1M $2M $3M $2M $1M $788
Current Assets 7-point trend, +776.3% $11M $25M $43M $59M $73M $20M $1M
PP&E (Net) 7-point trend, +264.0% $31.9K $47.4K $52.1K $48.0K $30.2K $21.5K $8.8K
Other Non-current Assets 5-point trend, +105.4% $36.7K $36.7K $25.9K $17.9K $17.9K · ·
Total Assets 7-point trend, +670.3% $11M $26M $44M $59M $74M $20M $1M
Accounts Payable 6-point trend, +700.8% $4M $4M $3M $3M $2M $552.3K ·
Current Liabilities 7-point trend, +820.0% $5M $4M $3M $3M $2M $552.3K $489.3K
Capital Leases 3-point trend, -0.1% · $52.8K $61.5K · $52.9K · ·
Total Liabilities 7-point trend, +820.0% $5M $4M $3M $3M $2M $660.8K $489.3K
Common Stock 7-point trend, +468.2% $1.1K $1.1K $1.1K $1.1K $1.1K $622 $198
Paid-in Capital 7-point trend, +1195.1% $100M $97M $96M $96M $97M $32M $8M
Retained Earnings 7-point trend, -1279.6% $-93M $-76M $-55M $-39M $-25M $-13M $-7M
AOCI 5-point trend, +127.4% $25.4K $154.0K $-107.5K $-371.4K $-92.7K · ·
Stockholders' Equity 7-point trend, +592.7% $7M $21M $41M $56M $72M $20M $943.3K
Liabilities + Equity 7-point trend, +670.3% $11M $26M $44M $59M $74M $20M $1M
Shares Outstanding 7-point trend, +468.9% 11,254,697 10,784,725 10,721,192 10,857,040 11,088,835 6,220,927 1,978,269
Cash Flow 12
Annual Cash Flow data for LTRN
Metric Trend 2025202420232022202120202019
D&A 7-point trend, +962.1% $17.3K $17.3K $14.6K $10.1K $6.8K $3.4K $1.6K
Stock-based Comp 5-point trend, -32.3% $651.0K $652.0K $1M $1M $961.5K · ·
Other Non-cash 4-point trend, +110.5% · · $532.9K $294.6K $2M $253.2K ·
Operating Cash Flow 7-point trend, -636.7% $-16M $-18M $-14M $-13M $-11M $-6M $-2M
CapEx 5-point trend, -88.9% $1.7K $12.6K $18.7K $27.8K $15.5K · ·
Investing Cash Flow 7-point trend, +193506.9% $11M $3M $-930.2K $179.3K $-20M $-16.1K $-5.7K
Stock Issued 2-point trend, -97.6% $2M · · · $69M · ·
Stock Repurchased 3-point trend, -46.8% · · $500.0K $2M $939.7K · ·
Net Stock Activity 2-point trend, +79.9% · · $-500.0K $-2M · · ·
Financing Cash Flow 7-point trend, -48.7% $1M $66.7K $-500.0K $-2M $63M $24M $3M
Net Change in Cash 7-point trend, -492.5% $-3M $-14M $-16M $-15M $33M $18M $786.9K
Free Cash Flow 2-point trend, -12.3% · · $-14M $-13M · · ·
Profitability 2
Annual Profitability data for LTRN
Metric Trend 2025202420232022202120202019
ROA 4-point trend, +42.5% · · -31.1% -21.5% -26.2% -54.2% ·
ROE 4-point trend, -29.2% · · -37.0% -24.8% -16.8% -28.6% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for LTRN
Metric Trend 2025202420232022202120202019
Current Ratio 4-point trend, -55.8% · · 16.2 21.0 31.3 36.6 ·
Quick Ratio 4-point trend, -55.7% · · 15.4 19.7 30.4 34.8 ·
Per Share 4
Annual Per Share data for LTRN
Metric Trend 2025202420232022202120202019
Book Value / Share 4-point trend, +20.5% · · $3.82 $5.16 $6.45 $3.17 ·
Cash Flow / Share · · $-1.32 · · · ·
Cash / Share 4-point trend, -33.8% · · $2.05 $3.43 $4.65 $3.09 ·
EPS (TTM) 4-point trend, -19.8% $-1.57 $-1.93 $-1.47 $-1.31 · · ·
Valuation (TTM) 8
Annual Valuation (TTM) data for LTRN
Metric Trend 2025202420232022202120202019
Net Income TTM 6-point trend, -189.8% $-17M $-21M $-16M $-14M $-12M $-6M ·
Market Cap 4-point trend, -61.7% · · $46M $66M $88M $120M ·
P/E 4-point trend, +58.1% -1.9 -1.7 -2.9 -4.6 · · ·
P/B 4-point trend, -81.5% · · 1.1 1.2 1.2 6.1 ·
P / Tangible Book 6-point trend, -14.2% 5.2 1.6 1.1 1.2 1.2 6.1 ·
P / Cash Flow 4-point trend, +84.9% · · -3.2 -5.1 -8.4 -21.2 ·
P / FCF 2-point trend, +37.7% · · -3.2 -5.1 · · ·
Earnings Yield 4-point trend, -138.9% -51.8% -60.5% -34.4% -21.7% · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Net Income $-17M$-21M$-16M$-14M$-12M
Diluted EPS $-1.57$-1.93$-1.47$-1.31
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 16.221.031.3
Quick Ratio 15.419.730.4
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-14M$-13M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 40 filers · $11.7M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
15 (+13 vs prior Q) 6 (+2 vs prior Q) 6 (-2 vs prior Q) 7 (-1 vs prior Q) +1.1M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Empery Asset Management, LP $3,513,930 842,669 29.95% Shares
CM Management, LLC $2,085,000 500,000 17.77% Shares
VANGUARD CAPITAL MANAGEMENT LLC $1,772,742 425,118 15.11% Shares
RENAISSANCE TECHNOLOGIES LLC $1,213,633 291,039 10.35% Shares
BIOS Capital Management, LP $1,039,985 249,397 8.87% Shares
GEODE CAPITAL MANAGEMENT, LLC $353,467 84,741 3.01% Shares
VANGUARD FIDUCIARY TRUST CO $208,292 49,950 1.78% Shares
Westside Investment Management, Inc. $199,537 47,850 1.70% Shares
Quadrature Capital Ltd $165,103 39,593 1.41% Shares
VANGUARD GROUP INC $150,309 49,607 1.28% Shares
NewEdge Advisors, LLC $112,796 27,049 0.96% Shares
HORIZON KINETICS ASSET MANAGEMENT LLC $104,934 25,164 0.89% Shares
DAVENPORT & Co LLC $99,304 23,814 0.85% Shares
STATE STREET CORP $98,629 23,652 0.84% Shares
Bank of New York Mellon Corp $88,821 21,300 0.76% Shares
NORTHERN TRUST CORP $72,912 17,485 0.62% Shares
XTX Topco Ltd $72,621 17,415 0.62% Shares
Focus Partners Wealth $64,351 15,432 0.55% Shares
DIMENSIONAL FUND ADVISORS LP $61,558 14,762 0.52% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $58,684 14,073 0.50% Shares
Cetera Investment Advisers $50,991 12,228 0.43% Shares
Farther Finance Advisors, LLC $45,766 10,975 0.39% Shares
UBS Group AG $27,105 6,500 0.23% Shares
BlackRock, Inc. $18,748 4,496 0.16% Shares
Vanguard Global Advisers, LLC $9,820 2,355 0.08% Shares
SIMPLEX TRADING, LLC $9,745 2,337 0.08% Shares
SBI Securities Co., Ltd. $9,003 2,159 0.08% Shares
CITADEL ADVISORS LLC $6,901 1,655 0.06% Shares
Tower Research Capital LLC (TRC) $4,846 1,162 0.04% Shares
MARSHALL WACE, LLP $4,804 1,152 0.04% Shares
ENTRUST FINANCIAL LLC $2,085 500 0.02% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $2,085 500 0.02% Shares
OSAIC HOLDINGS, INC. $917 220 0.01% Shares
Physician Wealth Advisors, Inc. $659 158 0.01% Shares
Rialto Wealth Management, LLC $513 123 0.00% Shares
PlanVest Financial, Inc $417 100 0.00% Shares
MORGAN STANLEY $121 29 0.00% Shares
GROUP ONE TRADING LLC $96 23 0.00% Shares
BARCLAYS PLC $25 6 0.00% Shares
Key Financial Inc $8 2 0.00% Shares

Company insiders 7 insiders · 3 officers · 5 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Panna Sharma President and CEO Aug. 6, 2022 A 0 0 $0
David R. Margrave Chief Financial Officer Oct. 29, 2021 A 0 0 $0
Kishor G. Bhatia Chief Scientific Officer Oct. 29, 2021 A 0 0 $0
Vijay Chandru Director Nov. 4, 2021 A 0 0 $0
David S. Silberstein Director Nov. 4, 2021 A 0 0 $0
Jeffrey D Keyser Director Nov. 4, 2021 A 41,927 0 0 $0
Franklyn G Prendergast Director Nov. 4, 2021 A 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 5 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
BIOS ADVISORS GP, LLC, AARON G.L. FLETCHER, CAVU MANAGEMENT, LP, CAVU ADVISORS, LLC, LESLIE W. KREIS, BIOS EQUITY PARTNERS, LP, BIOS EQUITY PARTNERS II, LP, BIOS CAPITAL MANAGEMENT, LP, BIOS FUND II NT, LP, BIOS FUND II QP, LP, BIOS FUND II, LP, BP DIRECTORS, LP, BIOS FUND I QP, LP, Bios Fund I, LP May 15, 2026 4.48% Amendment SEC
Bios Equity Partners, LP, Fletcher Aaron G.L., BIOS Advisors GP, LLC, BIOS Capital Management, LP, Bios Equity Partners II, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BP Directors, LP, Cavu Advisors, LLC, Cavu Management, LP, Kreis Leslie W. April 16, 2026 7.40% Amendment SEC
Bios Fund I, LP, BIOS EQUITY PARTNERS II, LP, BIOS FUND I QP, LP, BIOS FUND II, LP, BIOS FUND II QP, LP, BIOS FUND II NT, LP, BP DIRECTORS, LP, BIOS EQUITY PARTNERS, LP, BIOS CAPITAL MANAGEMENT, LP, BIOS ADVISORS GP, LLC, CAVU MANAGEMENT, LP, CAVU ADVISORS, LLC, LESLIE W. KREIS, AARON G.L. FLETCHER ×6 filings Feb. 23, 2026 8.58% Amendment SEC
Biological Mimetics, Inc., David S. Silberstein June 23, 2020 Initial filing SEC
Panna Sharma June 19, 2020 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 5 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
DFSU · Dimensional ETF Trust 0.00% 1,924 NS April 30, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 81,901 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 338,385 SH Aug. 8, 2026 Daily
DFAC · Dimensional ETF Trust 0.00% 1,042 NS April 30, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 4 NS April 30, 2026 N-PORT